Cargando…
Targeting Dendritic Cells in vivo for Cancer Therapy
Monoclonal antibodies that recognize cell surface molecules have been used deliver antigenic cargo to dendritic cells (DC) for induction of immune responses. The encouraging anti-tumor immunity elicited using this immunization strategy suggests its suitability for clinical trials. This review discus...
Autores principales: | Caminschi, Irina, Maraskovsky, Eugene, Heath, William Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342351/ https://www.ncbi.nlm.nih.gov/pubmed/22566899 http://dx.doi.org/10.3389/fimmu.2012.00013 |
Ejemplares similares
-
Splenic Dendritic Cells and Macrophages Drive B Cells to Adopt a Plasmablast Cell Fate
por: McNamara, Hayley A., et al.
Publicado: (2022) -
Autophagy for Better or Worse during Infectious Diseases
por: Caminschi, Irina, et al.
Publicado: (2013) -
A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo
por: Scales, Hannah E., et al.
Publicado: (2018) -
DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013) -
Mechanisms of Tolerance Induction by Dendritic Cells In Vivo
por: Hasegawa, Hitoshi, et al.
Publicado: (2018)